Spots Global Cancer Trial Database for metastases
Every month we try and update this database with for metastases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | NCT02414269 | Malignant Pleur... Mesothelioma Metastases Lung Cancer Breast Cancer | iCasp9M28z T ce... cyclophosphamid... pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer | NCT00095108 | Melanoma Kidney Neoplasm... Metastases | Recombinant Hum... | 18 Years - | ZymoGenetics | |
| Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases | NCT06173401 | Spinal Metastas... | Single-fraction... Multi-fraction ... | 18 Years - | Stanford University | |
| Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases | NCT06173401 | Spinal Metastas... | Single-fraction... Multi-fraction ... | 18 Years - | Stanford University | |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | NCT00537823 | Colorectal Canc... Metastases | Cetuximab Bevacizumab Leucovorin Oxaliplatin Fluorouracil | 18 Years - | Washington University School of Medicine | |
| Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer | NCT01325142 | Bone Diseases Metastases Osteonecrosis Bisphosphonate-... | 21 Years - | University of Michigan | ||
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
| Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases | NCT01169129 | Metastases Cancer | surgery radiosurgery | 18 Years - 64 Years | Barretos Cancer Hospital | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
| Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment | NCT04066322 | Neuroendocrine ... Metastases Surgery | system treatmen... system treatmen... | 18 Years - 80 Years | Fudan University | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| Exploratory Study of Breast Cancer With ABY025 | NCT01216033 | Breast Cancer | 111-In-ABY-025 | 20 Years - | Biomedical Radiation Sciences | |
| Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer | NCT02690480 | Breast Neoplasm... | PD-0332991 (Pal... Fulvestrant Placebo | 18 Years - | Spanish Breast Cancer Research Group | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| Stereotactic Radiosurgery (SRS) for Multiple CNS Mets | NCT02567643 | Metastatic Canc... Brain Metastase... | Stereotactic Ra... | - | The Cooper Health System | |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | NCT00569036 | Neoplasms Solid Tumors Metastases | BMS-754807 | 18 Years - | Bristol-Myers Squibb | |
| A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer | NCT00992745 | Prostate Cancer | 123-I-MIP-1072 111-In capromab... 123-I-MIP-1072 | 18 Years - | Molecular Insight Pharmaceuticals, Inc. | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors | NCT02156700 | Haemangioma Metastases Cholangiocellul... Hepatocellular ... Focal Nodular H... | Shear wave elas... | 18 Years - | University Hospital Dubrava | |
| Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy | NCT00918593 | Ulcerated Cutan... | Electrochemothe... Radiotherapy Bleomycin | 18 Years - | Copenhagen University Hospital at Herlev | |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. | NCT06022029 | Triple Negative... Diffuse Large B... Follicular Lymp... Lymphoma, Non-H... Mantle Cell Lym... Bladder Cancer Uveal Melanoma,... Cervix Cancer Carcinoma in Si... Head and Neck S... Skin Cancer Metastatic Canc... Tumor, Solid Tumor Recurrenc... | ONM-501 Cemiplimab | 18 Years - | OncoNano Medicine, Inc. | |
| Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. | NCT01844661 | Children Solid Tumors Metastases | CELYVIR | 6 Months - 75 Years | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | |
| A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin | NCT04059588 | Cancer Solid Tumor Cancer of Skin | 2141 V-11 | 18 Years - | Rockefeller University | |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane | NCT03003078 | Unresectable Lo... | OncoSil™ | 18 Years - | OncoSil Medical Limited | |
| Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | NCT00080301 | Breast Cancer Metastases | Ixabepilone + C... Capecitabine | 18 Years - | R-Pharm | |
| Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases | NCT00393965 | Brain Neoplasms | MPC-6827 | 18 Years - | Myrexis Inc. | |
| 68Ga-PSMA PET in the Prostate Cancer | NCT04967001 | Prostatic Neopl... Metastases PSMA-PET | PSMA PET | 40 Years - 90 Years | Xijing Hospital | |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | NCT00107861 | Colorectal Carc... Metastases | Ad.hIFN-β (BG00... | 18 Years - | Biogen | |
| Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 | NCT00970359 | Thyroid Cancer | AZD6244 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease | NCT01427322 | Epithelial Canc... | Lapatinib Radiation thera... | 18 Years - | Virginia Commonwealth University | |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | NCT00107861 | Colorectal Carc... Metastases | Ad.hIFN-β (BG00... | 18 Years - | Biogen | |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | NCT00569036 | Neoplasms Solid Tumors Metastases | BMS-754807 | 18 Years - | Bristol-Myers Squibb | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Systematic Evaluation of Human Explant Model Systems Engineering | NCT04671654 | Solid Tumor, Ad... | 18 Years - | University Hospital Heidelberg | ||
| Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. | NCT00305188 | Metastases Colorectal Neop... Colorectal Carc... | Xaliproden (SR5... Placebo Oxaliplatin 5-Fluorouracil Leucovorin | 18 Years - | Sanofi | |
| 68Ga-PSMA PET in the Prostate Cancer | NCT04967001 | Prostatic Neopl... Metastases PSMA-PET | PSMA PET | 40 Years - 90 Years | Xijing Hospital | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer | NCT00113763 | Colorectal Canc... Metastases | Best supportive... Panitumumab | 18 Years - | Amgen | |
| Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer | NCT03754569 | Epithelial Ovar... | Peritoneal biop... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Stereotactic Radiosurgery (SRS) for Multiple CNS Mets | NCT02567643 | Metastatic Canc... Brain Metastase... | Stereotactic Ra... | - | The Cooper Health System | |
| Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI | NCT00820456 | Colorectal Neop... Hepatic Neoplas... | DCE-MRI | 18 Years - | American College of Radiology | |
| MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | NCT00094653 | Melanoma Metastases | MDX-010 (anti-C... MDX-1379 (gp100... | 18 Years - | Bristol-Myers Squibb | |
| Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | NCT00081796 | Breast Cancer Metastases | larotaxel (RPR1... capecitabine | 18 Years - | Sanofi | |
| A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain | NCT00802659 | Metastases | Stereotactic ra... | 18 Years - | Washington University School of Medicine | |
| Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases | NCT00749697 | Thyroid Carcino... Metastatic Site... | SPECT scan | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases | NCT01169129 | Metastases Cancer | surgery radiosurgery | 18 Years - 64 Years | Barretos Cancer Hospital | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) | NCT00446446 | Cancer Carcinoma Head and Neck C... Metastases Metastatic Canc... Metastatic or R... Oncology Squamous Cell C... Tumors | Panitumumab | 18 Years - | Amgen | |
| Trastuzumab & Pertuzumab Followed by T-DM1 in MBC | NCT01835236 | Metastatic Brea... | Trastuzumab Pertuzumab Paclitaxel Vinorelbine T-DM1 | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy | NCT00083720 | Colorectal Neop... Metastases Neoplasm | cetuximab | 18 Years - | Eli Lilly and Company | |
| Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer | NCT00083304 | Breast Cancer Metastases | Efaproxiral Whole Brain Rad... Supplemental Ox... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients | NCT03891654 | Liver Cancer | Dynamic Contras... | 18 Years - 100 Years | University of Colorado, Denver | |
| Analysis of Tokuhashi Score | NCT01210508 | Cancer Metastases | 10 Years - | State University of New York - Upstate Medical University | ||
| Dexanabinol in Patients With Brain Cancer | NCT01654497 | Brain Cancer | Dexanabinol | 18 Years - | University of California, San Diego | |
| Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | NCT00081796 | Breast Cancer Metastases | larotaxel (RPR1... capecitabine | 18 Years - | Sanofi | |
| Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer | NCT01334983 | Cancer | REST | 18 Years - | Mayo Clinic | |
| Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER) | NCT02452294 | Malignant Melan... Metastases | Buparlisib | 18 Years - | University Hospital Tuebingen | |
| DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | NCT00099281 | Breast Cancer Metastases | YMB 1002 | 16 Years - | YM BioSciences | |
| Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) | NCT01216371 | Renal Cell Carc... Pulmonary Metas... | Sunitinib Placebo | 18 Years - 75 Years | Association of Urologic Oncology (AUO) | |
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer | NCT01337518 | Prostatic Neopl... | EZN-4176 | 18 Years - | Enzon Pharmaceuticals, Inc. | |
| A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) | NCT02166658 | Breast Cancer Lung Cancer Recurrent Brain... Progressive Bra... | Cabazitaxel | 18 Years - | AIO-Studien-gGmbH | |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy | NCT00083720 | Colorectal Neop... Metastases Neoplasm | cetuximab | 18 Years - | Eli Lilly and Company | |
| The Effect of Fish Oils on Human Hepatic Colorectal Metastases | NCT00942292 | Colorectal Live... | Lipidem- fish o... Digital Contras... | 18 Years - 80 Years | University Hospitals, Leicester | |
| Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | NCT00080301 | Breast Cancer Metastases | Ixabepilone + C... Capecitabine | 18 Years - | R-Pharm | |
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | NCT02414269 | Malignant Pleur... Mesothelioma Metastases Lung Cancer Breast Cancer | iCasp9M28z T ce... cyclophosphamid... pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients | NCT00080197 | Breast Neoplasm... Metastases | E7070 | 18 Years - | Eisai Inc. | |
| Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. | NCT01844661 | Children Solid Tumors Metastases | CELYVIR | 6 Months - 75 Years | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | |
| Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer | NCT01334983 | Cancer | REST | 18 Years - | Mayo Clinic | |
| Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors | NCT01678664 | Neuroendocrine ... Hepatic Metasta... Metastases | Everolimus embolization Doxorubicin | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen | NCT00324610 | Breast Neoplasm... Chemotherapy | capecitabine | 18 Years - | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | |
| XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | NCT00272051 | Metastases Colorectal Neop... Colorectal Carc... | SR57746A | 18 Years - | Sanofi | |
| Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer | NCT00083304 | Breast Cancer Metastases | Efaproxiral Whole Brain Rad... Supplemental Ox... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer | NCT01759238 | Colorectal Canc... Metastases | Capecitabine Bevacizumab Radiotherapy | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
| A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | NCT00096967 | Breast Cancer Colorectal Canc... Metastases | Avastin (bevaci... | - | Genentech, Inc. | |
| Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study | NCT00378638 | Breast Cancer | bevacizumab com... | 18 Years - | Chap, Linnea I., M.D. | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) | NCT00446446 | Cancer Carcinoma Head and Neck C... Metastases Metastatic Canc... Metastatic or R... Oncology Squamous Cell C... Tumors | Panitumumab | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
